The Pituitary Course will feature the following speakers:

Prof John Wass, the UK

Prof John Newell-Price, the UK

Prof Susan Webb, Spain

Prof Alberto Pereira, the Netherlands

Prof Vallo Volke, Estonia

Dr Kristina Isand, Estonia

Márta Korbonits


Márta Korbonits, MD, PhD, DSc, FRCP is Professor of Endocrinology and Metabolism at Barts and the London School of Medicine and Dentistry, Queen Mary University of London, is a graduate from the Semmelweis Medical School, Budapest. She was a Medical Research Council Clinician Scientist Fellow working on ghrelin and the hormonal regulation of the metabolic enzyme AMP-activated protein kinase and her latest study in the field showed the beneficial effects of AMPK stimulator metformin on glucocorticoid treated patients. She also works on endocrine tumorigenesis, especially the genetic origin of pituitary adenomas and other endocrine tumour syndromes. She studies both the clinical characterisation as well as molecular aspects of pituitary diseases and leads a large international consortium to study the genetic background of endocrine tumours. She published over 200 original papers (H-index 80 at Google Scholar). She shares her time between clinical patient care, clinical research and laboratory based research as well as teaching at undergraduate and postgraduate level. She was a recipient of several national and international awards and is an elected Member of the Hungarian Academy of Sciences. She is Deputy Editor of Endocrine-Related Cancer, Director of the HARP Clinical Doctoral Training Programme and President-Elect for the Society for Endocrinology.


Alberto M. Pereira


Alberto M. Pereira (Uruguay, 1966) is professor of Medicine, and Head of theDepartmentof Endocrinology&Metabolismat theAmsterdamUniversityMedical Center, the Netherlands. In 2012he was appointed as professor ofMedicine and chair of Endocrinology at Leiden University Medical Center, andfoundedthe Center for Endocrine Tumors, an (inter)national multidisciplinaryreference center for patient with endocrine tumors, based on patient-centeredcare pathways and VBHC, linking care and research. He was president of theEuropean Neuroendocrine Association (2016-2018), and at present is thecoordinator of the European Reference Network on Rare Endocrine Conditions(Endo-ERN), which aim is to reduce present health inequalities in Europe. Hisresearch focusses on the long-term effects of pituitary tumors and of itstreatment, and in specific on the effects of stress hormones on the centralnervous system. He authored more than 350 papers and book chapters, andpresently supervised 18PhD candidates (3 cum laude).He is the recipient ofthe 2022 ESE Clinical Endocrinology Trust Award.